医疗保健 CMO 市场：按服务类型和地区划分

全球医疗保健 CMO 市场预计 2024 年为 1,711 亿美元，预计到 2031 年将达到 4,471.1 亿美元，2024 年至 2031 年复合年增长率为 14.7%。

图：2024 年按地区分類的医疗保健 CMO市场占有率(%)

全球医疗保健 CMO 市场的成长是由全球对高品质药品不断增长的需求所推动的。製药和生物技术公司越来越多地将製造业务外包给受託製造厂商，以专注于其核心竞争力，例如研发、行销和销售。 CMO 提供端到端製造服务，从药物开发到临床试验供应、商业製造、包装和监管支援。这使得生物製药製造商能够降低製造成本并有效地遵守严格的监管标准。

市场动态：

全球医疗保健 CMO 市场的成长是由学名药和生物仿製药市场的扩张、对具有成本效益的药物製造外包解决方案的需求不断增长以及药物开发的研发投资增加等因素推动的。然而，生物製药开发的复杂性、技术纯熟劳工的缺乏以及对生产设施的严格监管可能会阻碍市场成长。进入该市场的公司有机会开拓亚太和拉丁美洲的新兴市场，这些市场可以获得低成本的製造地和熟练劳动力。领先的市场参与企业正在积极投资于产能扩张、先进技术和监管能力，以加强其服务组合和全球企业发展。

本研究的主要特点

本报告对全球医疗保健 CMO 市场进行了详细分析，并提供了以 2023 年为基准年的预测期（2024-2031 年）的市场规模（十亿美元）和年复合成长率（CAGR%）。它。

它还揭示了各个细分市场的潜在商机，并说明了该市场有吸引力的投资提案矩阵。

它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。

它包括基于公司亮点、产品系列、主要亮点、财务绩效和策略等参数的全球医疗保健 CMO 市场主要企业的概况。

本研究涵盖的主要企业包括 Catalent Inc.、Recipharm AB、Aurobindo Pharma Limited、Jubilant Life Sciences Ltd.、Boehringer Ingelheim GmbH、Lonza Group、Patheon Inc. 等。

该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。

全球医疗保健 CMO 市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。

透过用于分析全球医疗保健 CMO 市场的各种策略矩阵，将有助于相关人员做出决策。

目录

第一章 研究目的与前提

• 研究目的
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要

第三章市场动态、法规及趋势分析

• 市场动态
  • 促进因素
  • 抑制因素
  • 机会
• 影响分析
• 市场趋势
• 主要进展
• 监管场景
• 收购和合作场景
• 资金筹措和投资
• PEST分析
• 波特的分析

第四章全球医疗保健 CMO 市场 - 冠状病毒 (COVID-19) 大流行的影响

• 整体影响
• 政府倡议
• COVID-19 对市场的影响

第五章 全球医疗保健 CMO 市场，依服务类型，2019-2031

• 药品契约製造服务
• 活性药物成分 (API) 製造
• 最终剂型 (FDF) 製造包装
• 医疗设备契约製造服务
• 设计外包
• 装置製造
• 材料加工服务
• 电子设备製造服务
• 成品
• 最终产品组装

第六章 全球医疗保健 CMO 市场（按地区），2019-2031

• 拉丁美洲
• 欧洲
• 亚太地区
• 中东

第七章 竞争格局

• 公司简介
  • Lonza Group
  • Catalent, Inc.
  • Thermo Fisher Scientific（Patheon）
  • Recipharm AB
  • Siegfried Holding AG
  • Aenova Group
  • Almac Group
  • Piramal Pharma Solutions
  • Evonik Industries AG
  • Famar Health Care Services
  • Boehringer Ingelheim
  • Consort Medical plc
  • Pfizer CentreOne
  • Baxter BioPharma Solutions
  • Jubilant HollisterStier
  • Vetter Pharma International GmbH
  • Ajinomoto Bio-Pharma Services
  • Fareva Group

第八章 分析师建议

• 命运之轮
• 分析师观点
• 一致的机会图

第9章 参考文献及调查方法

• 参考
• 调查方法

Global healthcare CMO market is estimated to be valued at USD 171.10 Bn in 2024 and is expected to reach USD 447.11 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 14.7% from 2024 to 2031.

Figure. Healthcare CMO Market Share (%), By Region 2024

Global healthcare CMO market growth is driven by rising demand for high-quality pharmaceutical products across the world. Various pharmaceutical and biotechnology companies are increasingly outsourcing their manufacturing operations to contract manufacturing organizations, in order to focus on their core competencies of research and development, marketing and sales. The CMOs provide end-to-end manufacturing services right from drug development, clinical trial supplies, commercial manufacturing, packaging and regulatory support. This enables the biopharmaceutical players to reduce manufacturing costs and comply with stringent regulatory norms in a time-efficient manner.

Market Dynamics:

Global healthcare CMO market growth is driven by factors such as rising generic and biosimilar drugs market, growing demand for cost-effective pharmaceutical manufacturing outsourcing solutions, and increasing R&D investment in drug development. However, complexity in developing biological drugs, lack of skilled workforce and stringent regulations for manufacturing facilities can hamper the market growth. The companies in this market have opportunity to tap the emerging markets in Asia Pacific and Latin America, owing to availability of low-cost manufacturing base and skilled labor. Key market players are investing heavily in capacity expansion, advanced technologies and regulatory capabilities to strengthen their service portfolio and global footprint.

Key Features of the Study:

This report provides in-depth analysis of the global healthcare CMO market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global healthcare CMO market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Catalent Inc., Recipharm AB, Aurobindo Pharma Limited, Jubilant Life Sciences Ltd., Boehringer Ingelheim GmbH, Lonza Group, and Patheon Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global healthcare CMO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global healthcare CMO market

Detailed Segmentation-

• By Service Type
  • Pharmaceutical Contract Manufacturing Services
  • Active Pharmaceutical Ingredients (API) Manufacturing
  • Final Dosage Form (FDF) Manufacturing Packaging
  • Medical Device Contract Manufacturing Services
  • Outsourcing Design
  • Device Manufacturing
  • Material Process Services
  • Electronic Manufacturing Services
  • Finished Products
  • Final Goods Assembly
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Lonza Group
  • Catalent, Inc.
  • Thermo Fisher Scientific (Patheon)
  • Recipharm AB
  • Siegfried Holding AG
  • Aenova Group
  • Almac Group
  • Piramal Pharma Solutions
  • Evonik Industries AG
  • Famar Health Care Services
  • Boehringer Ingelheim
  • Consort Medical plc
  • Pfizer CentreOne
  • Baxter BioPharma Solutions
  • Jubilant HollisterStier
  • Vetter Pharma International GmbH
  • Ajinomoto Bio-Pharma Services
  • Fareva Group

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Service Type
  • Market Snapshot, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Healthcare CMO Market- Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Healthcare CMO Market, By Service Type, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Pharmaceutical Contract Manufacturing Services
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Active Pharmaceutical Ingredients (API) Manufacturing
• Final Dosage Form (FDF) Manufacturing Packaging
• Medical Device Contract Manufacturing Services
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Outsourcing Design
• Device Manufacturing
• Material Process Services
• Electronic Manufacturing Services
• Finished Products
• Final Goods Assembly

6. Global Healthcare CMO Market, By Region, 2019 - 2031, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2031
  • Regional Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

7. Competitive Landscape

• Company Profiles
  • Lonza Group
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Catalent, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Thermo Fisher Scientific (Patheon)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Recipharm AB
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Siegfried Holding AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Aenova Group
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Almac Group
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Piramal Pharma Solutions
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Evonik Industries AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Famar Health Care Services
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Boehringer Ingelheim
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Consort Medical plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Pfizer CentreOne
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Baxter BioPharma Solutions
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Jubilant HollisterStier
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Vetter Pharma International GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Ajinomoto Bio-Pharma Services
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Fareva Group
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

8. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

9. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact